Psilocybin prevents chemotherapy-related nerve injury and associated symptoms in preclinical models

Preclinical models means mice, not patients — remember that before anyone starts selling mushrooms as chemo insurance.

In a breakthrough study, researchers at The University of Texas MD Anderson Cancer Center discovered that psilocybin given before chemotherapy prevented the onset of nerve injury in preclinical models, even after repeated treatment cycles. The findings could help prevent pain, numbness and other common chemotherapy side effects.

Read it at Medical Xpress ↗

← Front page